Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study
Condition: Opioid-use Disorder Intervention: Behavioral: Reminders messages to improve adherence. Sponsors: Washington State University; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2020 Category: Research Source Type: clinical trials
Providing Suboxone and PrEP Using Telemedicine
Conditions: Opioid Use; Opioid-use Disorder; Risk Reduction; Hiv Interventions: Drug: Suboxone; Drug: PrEP Sponsor: Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2020 Category: Research Source Type: clinical trials